Your money for a run? Campaign finance in America

Your money for a run? Campaign finance in Ame...

Up next

Nukes of hazard: US-Russia arms treaty expires

The New START nuclear deal was signed in 2010 to restrict the number of strategic warheads and missiles America and Russia could amass. Will there be a new deal – and what will happen if not? How social media has helped fuel recruitment to cults. And our baldness correspondent br ...  Show more

Peter and the wolves: Mandelson falls but Epstein scandal spreads

Peter Mandelson was a totem of Britain’s Labour party for decades. The newest Epstein files mark the end of his political career. What are the consequences for the country’s prime minister, Sir Keir Starmer? Ryanair is controversial and widely hated—yet strangely successful. And ...  Show more

Recommended Episodes

Your money for a run? Campaign finance in America
Economist Podcasts

Kamala Harris has proven to be an enormous draw for campaign donors. But the size of a candidate’s war chest influences the outcome much less than it once did. Our correspondent meets asylum-seekers on a Dutch ship, investigating the new hard-right government’s tactics with migra ...  Show more

Last-ditch pitch: America’s campaigns conclude
Economist Podcasts

Both campaigns have racked up air miles covering the swing states that will decide America’s knife-edge election. We take a measure of things one day before the vote. The Turkic states of central Asia once depended heavily on Russia; now they are banding together to counterbalanc ...  Show more

Keep Kamala and carry on: Harris’s smooth route
Economist Podcasts

A day is a long time in American politics: Kamala Harris has reportedly already secured the votes to become Democrats’ presidential nominee, a pile of campaign cash and the Trump campaign’s attention. For insight into how China treats its startup scene, we count the dwindling num ...  Show more

Don wan: Harris keeps Trump tame
Economist Podcasts

The vice-president turned in a confident if imperfect performance, leaving Donald Trump flustered. But will it change anything? A global shortfall of blood plasma is hampering the development of new medicines; we argue for some simple market forces that could plug the gap (11:40) ...  Show more